title: Sulphamoylated 2-methoxyestradiol analogues induce apoptosis in adenocarcinoma cell lines.
abstract: 2-Methoxyestradiol (2ME2) is a naturally occurring estradiol metabolite which possesses antiproliferative, antiangiogenic and antitumor properties. However, due to its limited biological accessibility, synthetic analogues have been synthesized and tested in attempt to develop drugs with improved oral bioavailability and efficacy. The aim of this study was to evaluate the antiproliferative effects of three novel in silico-designed sulphamoylated 2ME2 analogues on the HeLa cervical adenocarcinoma cell line and estrogen receptor-negative breast adenocarcinoma MDA-MB-231 cells. A dose-dependent study (0.1-25 μM) was conducted with an exposure time of 24 hours. Results obtained from crystal violet staining indicated that 0.5 μM of all 3 compounds reduced the number of cells to 50%. Lactate dehydrogenase assay was used to assess cytotoxicity, while the mitotracker mitochondrial assay and caspase-6 and -8 activity assays were used to investigate the possible occurrence of apoptosis. Tubulin polymerization assays were conducted to evaluate the influence of these sulphamoylated 2ME2 analogues on tubulin dynamics. Double immunofluorescence microscopy using labeled antibodies specific to tyrosinate and detyrosinated tubulin was conducted to assess the effect of the 2ME2 analogues on tubulin dynamics. An insignificant increase in the level of lactate dehydrogenase release was observed in the compounds-treated cells. These sulphamoylated compounds caused a reduction in mitochondrial membrane potential, cytochrome c release and caspase 3 activation indicating apoptosis induction by means of the intrinsic pathway in HeLa and MDA-MB-231 cells. Microtubule depolymerization was observed after exposure to these three sulphamoylated analogues.
authors.affiliation: Department of Physiology, University of Pretoria, Pretoria, South Africa.
authors.forename: Michelle
authors.initials: M
authors.lastname: Visagie
authors.forename: Anne
authors.initials: A
authors.lastname: Theron
authors.forename: Thandi
authors.initials: T
authors.lastname: Mqoco
authors.forename: Warren
authors.initials: W
authors.lastname: Vieira
authors.forename: Renaud
authors.initials: R
authors.lastname: Prudent
authors.forename: Anne
authors.initials: A
authors.lastname: Martinez
authors.forename: Laurence
authors.initials: L
authors.lastname: Lafanechère
authors.forename: Annie
authors.initials: A
authors.lastname: Joubert
mesh_terms: D000077584:2-Methoxyestradiol; D000230:Adenocarcinoma; D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D053148:Caspase 3 / Q000378:metabolism; D048430:Cell Shape / Q000187:drug effects; D045304:Cytochromes c / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D004789:Enzyme Activation; D004958:Estradiol / Q000031:analogs & derivatives* / Q000494:pharmacology; D006367:HeLa Cells; D006801:Humans; D053078:Membrane Potential, Mitochondrial / Q000187:drug effects; D046529:Microscopy, Electron, Transmission; D008870:Microtubules / Q000378:metabolism; D055503:Protein Multimerization / Q000187:drug effects; D013449:Sulfonamides / Q000494:pharmacology; D014404:Tubulin / Q000737:chemistry / Q000378:metabolism; D050257:Tubulin Modulators / Q000494:pharmacology
chemical_list: D000970:Antineoplastic Agents; D013449:Sulfonamides; D014404:Tubulin; D050257:Tubulin Modulators; D004958:Estradiol; D000077584:2-Methoxyestradiol; D045304:Cytochromes c; C505407:CASP3 protein, human; D053148:Caspase 3
references.citation: Cancer Res. 2007 Jan 15;67(2):702-8
references.pmid: 17234781
references.citation: Clin Cancer Res. 2008 Jan 15;14(2):597-606
references.pmid: 18223236
references.citation: Biocell. 2010 Aug;34(2):71-9
references.pmid: 20925196
references.citation: Br J Cancer. 2007 Dec 17;97(12):1673-82
references.pmid: 18026194
references.citation: Br J Cancer. 2008 Dec 2;99(11):1842-8
references.pmid: 18985042
references.citation: Anticancer Res. 2008 May-Jun;28(3A):1483-91
references.pmid: 18630502
references.citation: J Biol Chem. 1985 Mar 10;260(5):2819-25
references.pmid: 3972806
references.citation: Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2007 Apr;15(2):296-301
references.pmid: 17493335
references.citation: Gynecol Oncol. 2009 Oct;115(1):90-96
references.pmid: 19577796
references.citation: Int J Cancer. 2005 Oct 20;117(1):150-9
references.pmid: 15880363
references.citation: Chem Biol Drug Des. 2011 Mar;77(3):173-81
references.pmid: 21244635
references.citation: Drug Discov Today. 2007 Jul;12(13-14):577-84
references.pmid: 17631253
references.citation: Br J Cancer. 2004 Feb 23;90(4):932-7
references.pmid: 14970876
references.citation: Cell Biochem Funct. 2009 Jun;27(4):205-10
references.pmid: 19343733
references.citation: J Steroid Biochem Mol Biol. 1995 Dec;55(3-4):395-403
references.pmid: 8541236
references.citation: J Steroid Biochem Mol Biol. 2003 Jan;84(1):51-6
references.pmid: 12648524
references.citation: Int J Cancer. 2004 Apr 20;109(4):533-40
references.pmid: 14991574
references.citation: J Steroid Biochem Mol Biol. 2003 Feb;84(2-3):351-8
references.pmid: 12711022
references.citation: Rapid Commun Mass Spectrom. 2005;19(9):1176-82
references.pmid: 15818726
references.citation: J Steroid Biochem Mol Biol. 2005 Feb;94(1-3):219-27
references.pmid: 15862969
references.citation: Biocell. 2009 Apr;33(1):67-70
references.pmid: 19499887
references.citation: Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3964-8
references.pmid: 8171020
references.citation: Biocell. 2010 Dec;34(3):113-20
references.pmid: 21443141
references.citation: J Steroid Biochem Mol Biol. 2011 May;125(1-2):39-45
references.pmid: 21356310
references.citation: Biochemistry. 1991 Oct 29;30(43):10523-8
references.pmid: 1931974
references.citation: J Steroid Biochem Mol Biol. 2003 Sep;86(3-5):423-32
references.pmid: 14623540
references.citation: Cell Biochem Funct. 2010 Jul;28(5):412-9
references.pmid: 20589734
references.citation: Apoptosis. 2004 May;9(3):323-32
references.pmid: 15258464
references.citation: Arch Biochem Biophys. 2001 Aug 15;392(2):349-53
references.pmid: 11488612
references.citation: Expert Rev Neurother. 2008 Oct;8(10):1457-73
references.pmid: 18928341
references.citation: Breast Cancer Res Treat. 2008 Sep;111(2):251-60
references.pmid: 17957467
references.citation: Cancer Metastasis Rev. 2000;19(1-2):173-9
references.pmid: 11191057
references.citation: Br J Pharmacol. 2013 Feb;168(3):673-85
references.pmid: 23004938
references.citation: Oncologist. 2007 Apr;12(4):370-4
references.pmid: 17470679
references.citation: Cancer Res. 2002 Jul 1;62(13):3691-7
references.pmid: 12097276
references.citation: Br J Cancer. 2009 Feb 10;100(3):476-86
references.pmid: 19156141
references.citation: Anticancer Res. 2000 Jul-Aug;20(4):2641-5
references.pmid: 10953337
references.citation: Anticancer Res. 2008 Mar-Apr;28(2A):577-81
references.pmid: 18506995
references.citation: Exp Eye Res. 2006 Nov;83(5):1102-7
references.pmid: 16828472
references.citation: Comb Chem High Throughput Screen. 2008 Sep;11(8):617-23
references.pmid: 18795881
references.citation: Mol Interv. 2011 Apr;11(2):141-50
references.pmid: 21540474
references.citation: Cell Mol Biol Lett. 2010 Dec;15(4):564-81
references.pmid: 20697831
references.citation: Anal Biochem. 1986 Nov 15;159(1):109-13
references.pmid: 3812988
references.citation: J Cell Biol. 2006 Sep 11;174(6):839-49
references.pmid: 16954346
references.citation: Mol Cancer Ther. 2010 Jan;9(1):224-35
references.pmid: 20053769
references.citation: J Cell Sci. 1994 Jun;107 ( Pt 6):1529-43
references.pmid: 7962195